These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 9058987

  • 1. Prodigiosin 25-C and metacycloprodigiosin suppress the bone resorption by osteoclasts.
    Woo JT, Ohba Y, Tagami K, Sumitani K, Kataoka T, Nagai K.
    Biosci Biotechnol Biochem; 1997 Feb; 61(2):400-2. PubMed ID: 9058987
    [Abstract] [Full Text] [Related]

  • 2. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.
    Ohkuma S, Sato T, Okamoto M, Matsuya H, Arai K, Kataoka T, Nagai K, Wasserman HH.
    Biochem J; 1998 Sep 15; 334 ( Pt 3)(Pt 3):731-41. PubMed ID: 9729483
    [Abstract] [Full Text] [Related]

  • 3. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
    Sørensen MG, Henriksen K, Neutzsky-Wulff AV, Dziegiel MH, Karsdal MA.
    J Bone Miner Res; 2007 Oct 15; 22(10):1640-8. PubMed ID: 17576165
    [Abstract] [Full Text] [Related]

  • 4. Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.
    Woo JT, Ohba Y, Tagami K, Sumitani K, Yamaguchi K, Tsuji T.
    Biol Pharm Bull; 1996 Feb 15; 19(2):297-9. PubMed ID: 8850326
    [Abstract] [Full Text] [Related]

  • 5. Prodigiosins as a new group of H+/Cl- symporters that uncouple proton translocators.
    Sato T, Konno H, Tanaka Y, Kataoka T, Nagai K, Wasserman HH, Ohkuma S.
    J Biol Chem; 1998 Aug 21; 273(34):21455-62. PubMed ID: 9705273
    [Abstract] [Full Text] [Related]

  • 6. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y.
    Bone; 2007 Aug 21; 41(2):165-74. PubMed ID: 17560185
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase.
    Laitala T, Väänänen HK.
    J Clin Invest; 1994 Jun 21; 93(6):2311-8. PubMed ID: 8200964
    [Abstract] [Full Text] [Related]

  • 8. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
    Huang J, Yuan L, Wang X, Zhang TL, Wang K.
    Life Sci; 2007 Aug 16; 81(10):832-40. PubMed ID: 17764702
    [Abstract] [Full Text] [Related]

  • 9. Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo similar to that of concanamycin B, a specific inhibitor of vacuolar type H(+)-ATPase.
    Lee MH, Kataoka T, Magae J, Nagai K.
    Biosci Biotechnol Biochem; 1995 Aug 16; 59(8):1417-21. PubMed ID: 7549091
    [Abstract] [Full Text] [Related]

  • 10. Prodigiosin 25-C uncouples vacuolar type H(+)-ATPase, inhibits vacuolar acidification and affects glycoprotein processing.
    Kataoka T, Muroi M, Ohkuma S, Waritani T, Magae J, Takatsuki A, Kondo S, Yamasaki M, Nagai K.
    FEBS Lett; 1995 Feb 06; 359(1):53-9. PubMed ID: 7851530
    [Abstract] [Full Text] [Related]

  • 11. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H, Okamoto F, Li JP, Nakao A, Okabe K.
    J Bone Miner Res; 2006 Jul 06; 21(7):984-92. PubMed ID: 16813519
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Possible mechanism of the specific action of bisphosphonates on osteoclasts].
    Udagawa N.
    Nihon Rinsho; 2003 Feb 06; 61(2):207-12. PubMed ID: 12638209
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
    Lerner UH, Johansson L, Ranjsö M, Rosenquist JB, Reinholt FP, Grubb A.
    Acta Physiol Scand; 1997 Sep 06; 161(1):81-92. PubMed ID: 9381954
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. S 12911-2 inhibits osteoclastic bone resorption in vitro.
    Takahashi N, Sasaki T, Tsouderos Y, Suda T.
    J Bone Miner Res; 2003 Jun 06; 18(6):1082-7. PubMed ID: 12817762
    [Abstract] [Full Text] [Related]

  • 18. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption.
    Qin A, Cheng TS, Pavlos NJ, Lin Z, Dai KR, Zheng MH.
    Int J Biochem Cell Biol; 2012 Sep 06; 44(9):1422-35. PubMed ID: 22652318
    [Abstract] [Full Text] [Related]

  • 19. Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.
    Mulari MT, Qu Q, Härkönen PL, Väänänen HK.
    Calcif Tissue Int; 2004 Sep 06; 75(3):253-61. PubMed ID: 15148559
    [Abstract] [Full Text] [Related]

  • 20. Proton channel part of vacuolar H(+)-ATPase and carbonic anhydrase II expression is stimulated in resorbing osteoclasts.
    Laitala T, Väänänen K.
    J Bone Miner Res; 1993 Jan 06; 8(1):119-26. PubMed ID: 8427045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.